See also this year's filing and all EDGAR filings for this company.
PDF Report 0001467652_2018_Neos_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001467652')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001467652, Neos Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 82,640,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 16,348,000 |
| 2 | PropertyPlantAndEquipmentNet | 8,203,000 |
| 3 | remainder_Assets | 162,000 |
| 4 | LiabilitiesCurrent | 37,602,000 |
| 5 | LiabilitiesNoncurrent | 61,861,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 12,391,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,805,000 |
| 9 | ResearchAndDevelopmentExpense | 8,957,000 |
| 10 | remainder_Expenses | 46,881,000 |
| 11 | remainder_Revenues | 25,018,000 |
| 12 | remainder_NetIncome | -9,231,000 |
| 13 | remainder_ComprehensiveNetIncome | -5,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 107,353,000 |
| 1 | Liabilities | 99,463,000 |
| 2 | Expenses | 82,034,000 |
| 3 | Revenues | 25,018,000 |
| 4 | StockholdersEquity | 7,890,000 |
| 5 | NetIncome | -66,247,000 |
| 6 | ComprehensiveNetIncome | -66,249,500 |
| 7 | BaseVar | 161,552,000 |
| 8 | EconomicCapitalRatio | -0.509 |